Study to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic Disorder
Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
CV185118 is a single dose Apixaban PK/PD study in pediatric participants. The objective of
this study is primarily to study the PK/PD of Apixaban in pediatric participants at risk for
thrombosis